AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8757567
Drug: r‐HuEPO therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r‐HuEPO therapy
Trial: 2864775
Drug: Timolol and
RxNorm normalized name: timolol and thiazides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol and aceclidine combination
Trial: 31317553
Drug: Robotic-assisted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Robotic-assisted therapy with bilateral practice (RTBP)
Trial: 20351325
Drug: 80 IU/m(2)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 IU/m(2) of pegylated arginine deiminase (ADI) weekly for up to 6 months
Trial: 17506785
Drug: Dabigatran etexilate
RxNorm normalized name: Dabigatran etexilate
DrugBank: Dabigatran etexilate (DB06695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dabigatran etexilate (10-400 mg single doses or 50-400 mg three times daily for 6 days)
Trial: 15474697
Drug: Statin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin treatment started at least 3 days before the procedure
Trial: 11486456
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with 1% lanoconazole cream and 10% urea ointment (Pastaron)
Trial: 9743849
Drug: Propofol 3
RxNorm normalized name: fospropofol 35 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 3 mg
Trial: 9743849
Drug: Propofol 9
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol 9 mg
Trial: 9743849
Drug: Propofol 27
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol 27 mg
Trial: 2899062
Drug: Ro 16-8714
RxNorm normalized name: RO-5045337
DrugBank: RO-5045337 (DB14793)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ro 16-8714 (0.17 mg/kg fat free mass)
Trial: 24044216
Drug: Peginterferon alpha‐2a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peginterferon alpha‐2a combined with entecavir for 12 weeks, then Peginterferon alpha‐2a monotherapy for 36 weeks (Group C)
Trial: 20307262
Drug: SCION‐PAIN program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCION‐PAIN program (additional to standard pain treatment)
Trial: 17951035
Drug: HHQ-free coffee
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HHQ-free coffee (zero-dose)
Trial: 17951035
Drug: HHQ-free coffee
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HHQ-free coffee (middle-dose)
Trial: 17951035
Drug: HHQ-free coffee
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HHQ-free coffee (high-dose)
Trial: 16750285
Drug: Alveolar vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alveolar vaccination (controlled inhalation of Pneumovax)
Trial: 16750285
Drug: Bronchial vaccination
RxNorm normalized name: Bronchitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bronchial vaccination (controlled inhalation of Pneumovax)
Trial: 16750285
Drug: Standard intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard intramuscular vaccination (control group)
Trial: 2127537
Drug: Low-dose amiodarone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose amiodarone with low-dose flecainide
Trial: 21341932
Drug: Fast track
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast track diagnosis and treatment program for CRC
Trial: 17996561
Drug: Candesartan (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (titrated to a target of 32 mg once daily)
Trial: 31512072
Drug: UV irradiated
RxNorm normalized name: Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UV irradiated surface-treated implants
Trial: 31512072
Drug: Original surface
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Original surface implants (control)
Trial: 28921814
Drug: Nabilone 2
RxNorm normalized name: nabilone 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabilone 2 mg/day for 10 weeks
Trial: 25528200
Drug: Carvedilol 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol 2.5 mg
Trial: 25528200
Drug: Carvedilol 5
RxNorm normalized name: carvedilol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol 5 mg
Trial: 24798657
Drug: Carvedilol 20
RxNorm normalized name: Carvedilol 20mg Oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol 20 mg
Trial: 25528200
Drug: Carvedilol (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (all doses)
Trial: 19296355
Drug: Potentially effective
RxNorm normalized name: Potentilla discolor whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potentially effective treatments
Trial: 340005
Drug: Subcutaneous saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous saline
Trial: 16675939
Drug: Remifentanil 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil 0.25 mg kg(‐1) h(‐1)
Trial: 16675939
Drug: Fentanyl 2‐3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 2‐3 mg kg(‐1) h(‐1)
Trial: 15251635
Drug: Insulin-glucose infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-glucose infusion for at least 24 hours followed by long-term subcutaneous insulin treatment
Trial: 15251635
Drug: Insulin treatment
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin treatment in patients without prior insulin treatment
Trial: 11744471
Drug: Finasteride (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride (5 mg daily for 3 months)
Trial: 2499466
Drug: Multiple insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multiple insulin injections (MII)
Trial: 31366262
Drug: Alogliptin (once-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alogliptin (once-daily DPP-4i)
Trial: 31366262
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (Alogliptin and Trelagliptin)
Trial: 27510533
Drug: Nonalkalized cocoa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonalkalized cocoa mixture containing 0.6 mg epicatechin, 0.2 mg catechin, and 2.9 mg monomer-decamer procyanidins/kg body weight
Trial: 27510533
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of epicatechin and nonalkalized cocoa mixture containing 1.6 mg epicatechin/kg body weight
Trial: 24476418
Drug: Inhaled tobramycin
RxNorm normalized name: tobramycin Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled tobramycin with concomitant azithromycin
Trial: 22626813
Drug: I-gel prewarmed
RxNorm normalized name: iobenguane I-131
FDA approved: no
EMA approved: no
PMDA approved: no
Description: I-gel prewarmed to 37 °C
Trial: 22626813
Drug: I-gel kept
RxNorm normalized name: iobenguane I-131
FDA approved: no
EMA approved: no
PMDA approved: no
Description: I-gel kept at room temperature (approximately 20 °C)
Trial: 20724949
Drug: Oral L-arginine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral L-arginine supplementation (0.1, 0.2, and 0.4 g/kg)
Trial: 20724949
Drug: Oral L-arginine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral L-arginine supplementation
Trial: 29483030
Drug: Intranasal live
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal live attenuated influenza vaccine (LAIV)
Trial: 18597900
Drug: Intramuscular trivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular trivalent inactivated influenza vaccine (TIV)
Trial: 16888425
Drug: Sildenafil citrate
RxNorm normalized name: Sildenafil Citrate
DrugBank: Sildenafil (DB00203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sildenafil citrate (50 mg)
Trial: 11487753
Drug: High iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High iron formula (20.7 mg iron/L)
Trial: 11487753
Drug: Normal iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal iron formula (13.4 mg iron/L)
Trial: 8701624
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g cefotiam
Trial: 31128285
Drug: No antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotic treatment
Trial: 31296251
Drug: Placebo (0.9%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0.9% saline) administered in identical volume and manner as the treatment group
Trial: 28596642
Drug: Saxagliptin 5
RxNorm normalized name: sAXagliptin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saxagliptin 5 mg daily for 3 months
Trial: 19108791
Drug: Atenolol 25
RxNorm normalized name: atenolol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 25 mg plus lisinopril 5 mg
Trial: 6852987
Drug: Atenolol 25
RxNorm normalized name: atenolol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 25 mg
Trial: 8877596
Drug: Lisinopril 5
RxNorm normalized name: lisinopril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril 5 mg
Trial: 16258445
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of chemotherapy and radiation
Trial: 9418187
Drug: Paternal lymphocyte
RxNorm normalized name: Therapeutic allogeneic lymphocytes
DrugBank: Therapeutic allogeneic lymphocytes (DB17459)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paternal lymphocyte immunotherapy (control group).
Trial: 26428322
Drug: Daily CSF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily CSF output threshold of 78 mL
Trial: 23275415
Drug: Multiple oppositions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple oppositions approach (once weekly for 24 weeks)
Trial: 10554799
Drug: Fluconazole (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (100 mg)
Trial: 2059298
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (low-dose cyclosporin A, low-dose methylprednisolone, azathioprine)
Trial: 2059298
Drug: Aza and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aza and CyA (double drug treatment)
Trial: 2059298
Drug: Aza and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aza and MP (double drug treatment)
Trial: 28069480
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol (400 μg)
Trial: 8548054
Drug: Melatonin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (100 mg)
Trial: 18561728
Drug: Oral ibuprofen
RxNorm normalized name: ibuprofen Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ibuprofen (1 x 10 mg/kg, then 2 x 5 mg/kg at 24‐hour intervals)
Trial: 18561728
Drug: Oral indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral indomethacin (3 x 0.2 mg/kg at 24‐hour intervals)
Trial: 17605699
Drug: Educational Quality
RxNorm normalized name: DIABETES PATIENT EDUCATION PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Educational Quality Use of Medicines program (academic detailing, prescribing information, feedback, medication risk assessment, medication review facilitation, financial incentives)
Trial: 17605699
Drug: Educational Quality
RxNorm normalized name: DIABETES PATIENT EDUCATION PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Educational Quality Use of Medicines program
Trial: 11111068
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg per hour sustained-release polymer vaginal prostaglandin E(2) insert
Trial: 3486546
Drug: Naloxone (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (0.8 mg, 2 ml) injected i.v. after arm exercise
Trial: 29900538
Drug: HMW adiponectin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HMW adiponectin <1.53 μg/mL
Trial: 22231540
Drug: Balneotherapy (hot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balneotherapy (hot spring immersion at 40°C for 10 min daily for 2 weeks)
Trial: 22231540
Drug: Control (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (daily shower)
Trial: 19633594
Drug: Closed safe
RxNorm normalized name: Safe-Guard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Closed safe intravenous system (COSMOS - Compact Closed System)
Trial: 15967695
Drug: Intranasal saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal saline challenge
Trial: 7679885
Drug: Cold therapy
RxNorm normalized name: Deep Cold Therapy
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold therapy (Hot/Ice Thermal Blanket) applied to 13 patients
Trial: 18044260
Drug: Pioglitazone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (30 mg) plus voglibose
Trial: 9621668
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose fentanyl anesthesia (100 micrograms.kg‐1)
Trial: 29996082
Drug: H4:IC31 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H4:IC31 vaccine
Trial: 25447444
Drug: Lidocaine infusion
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine infusion 2 mg/kg/h after bolus 1.5 mg/kg
Trial: 25447444
Drug: Combined infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined infusion of lidocaine and dexmedetomidine
Trial: 20224901
Drug: SEIQoL-DW intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SEIQoL-DW intervention administered 3-5 times per patient
Trial: 1325831
Drug: Nitrendipine 20
RxNorm normalized name: nitrendipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine 20 mg o.d.
Trial: 26428409
Drug: Palifermin, 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palifermin, 60 μg/kg, intravenously as a single dose 3 days before and 0, +1, and +2 post autologous HSCT infusion
Trial: 19462314
Drug: Candesartan-HCT combination
RxNorm normalized name: candesartan / hydrochlorothiazide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan-HCT combination therapy (candesartan 2-32 mg and HCT 6.25-25 mg)
Trial: 10072988
Drug: qi-gong therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: qi-gong therapy (group b: 12 GYSK cases, group c: 19 YXYK cases)
Trial: 10072988
Drug: nifedipine therapy
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: nifedipine therapy (group d)
Trial: 7129331
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg nifedipine
Trial: 17616556
Drug: Celecoxib 200
RxNorm normalized name: celecoxib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 200 mg once a day
Trial: 16221219
Drug: Celecoxib 200
RxNorm normalized name: celecoxib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 200 mg twice a day
Trial: 18434566
Drug: Diclofenac 75
RxNorm normalized name: CAPSAICIN 0.025%/DICLOFENAC 75MG KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 75 mg twice a day
Trial: 31215676
Drug: Oral amoxicillin
RxNorm normalized name: amoxicillin Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amoxicillin tablets (875 mg)
Trial: 31215676
Drug: Oral amoxicillin
RxNorm normalized name: amoxicillin Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amoxicillin suspension (800 mg)
Trial: 28532232
Drug: Mixed hydro-alcoholic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixed hydro-alcoholic solution of P. alkekengi, E. amoenum and V. odorata extracts (1.5, 1 and 1.5% respectively)
Trial: 16946176
Drug: T(3) augmentation
RxNorm normalized name: levothyroxine sodium 0.3 MG [Levo-T]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T(3) augmentation (up to 50 mug/day; N=73)
Trial: 31820605
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of paclitaxel liposome and cisplatin
Trial: 21247651
Drug: 3% solution
RxNorm normalized name: Proxacol 3% Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% solution of tannin rich plant extracts (AS-21) applied topically for 6 weeks
Trial: 28258664
Drug: Patient-controlled intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled intravenous analgesia (group P)
Trial: 10755669
Drug: Individual psychotherapy
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individual psychotherapy in combination with antipsychotic medications
Trial: 8864420
Drug: Loxiglumide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loxiglumide (10 mg kg-1 h-1)
Trial: 1847977
Drug: Combined chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined chemotherapy and radiotherapy (group B)
Trial: 6679507
Drug: Intravenous labetalol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous labetalol (1-2 mg/kg; mean dose 86.5 mg)
Trial: 6679507
Drug: Diazoxide (3-5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazoxide (3-5 mg/kg; mean dose 253.8 mg)
Trial: 21288209
Drug: Pregabalin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (75 mg)
Trial: 15492491
Drug: Higher adherence
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher adherence to early treatment for JCP
Trial: 15492491
Drug: Low adherence
RxNorm normalized name: dressing,low adherence and wound contact materials
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low adherence to early treatment for JCP
Trial: 9001779
Drug: Gestrinone (Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gestrinone (Group G)
Trial: 7029276
Drug: Oral propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral propranolol (doses that reduced heart rate by 25%)
Trial: 26886327
Drug: Cefaclor standard
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefaclor standard release (SF) 750 mg
Trial: 26886327
Drug: Cefaclor modified
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefaclor modified release form (MRF) 750 mg
Trial: 23074432
Drug: Intensive counselling
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive counselling or a combination of intensive counselling and nicotine replacement therapy (NRT)
Trial: 9863502
Drug: Fansidar one
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fansidar one tablet weekly
Trial: 24417563
Drug: Peri-implant defect
RxNorm normalized name: casanthranol / docusate sodium Oral Capsule [Peri-Colace]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peri-implant defect reconstruction with porous titanium granules
Trial: 18777489
Drug: Muraglitazar 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Muraglitazar 2.5 mg plus metformin
Trial: 23086138
Drug: Glimepiride 1
RxNorm normalized name: glimepiride 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glimepiride 1 mg
Trial: 1998019
Drug: Methyl prednisolone
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methyl prednisolone (16 mg in 40 cc saline, concentration 40 mg%)
Trial: 1998019
Drug: Gel-saline double-lumen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gel-saline double-lumen implant with 40 cc saline
Trial: 6359384
Drug: Amoxycillin (375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin (375 mg, three times daily for 7 days)
Trial: 6359384
Drug: Cefaclor (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor (250 mg, three times daily for 7 days)
Trial: 31448789
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of piperacillin/tazobactam (TZP) 300 mg/kg/day after an initial loading dose of 75 mg/kg over 30 min.
Trial: 31448789
Drug: Intermittent infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent infusion of piperacillin/tazobactam (TZP) 300 mg/kg/day divided into four doses, not exceeding 16 g/day.
Trial: 30297911
Drug: Neoadjuvant ipilimumab
RxNorm normalized name: Ipilimumab
DrugBank: Ipilimumab (DB06186)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Neoadjuvant ipilimumab 3 mg kg−1 and nivolumab 1 mg kg−1
Trial: 30297911
Drug: Adjuvant ipilimumab
RxNorm normalized name: Ipilimumab
DrugBank: Ipilimumab (DB06186)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adjuvant ipilimumab 3 mg kg−1 and nivolumab 1 mg kg−1
Trial: 20680859
Drug: Medicine companions
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicine companions (MCs) chosen by participants for ART adherence support
Trial: 18203070
Drug: Extended Daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended Daily Dialysis with filtration (EDDf)
Trial: 12468775
Drug: ZK200775 (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZK200775 (dose group 2: 525 mg in 48 hours)